Showing results (81-90 of 1,205) with videos related to

Sort By:
Pageof 121
Wiener Medizinische Wochenschrift (1946)|November 11, 2008
Lessons from the toxic bile concept for the pathogenesis and treatment of cholestatic liver diseasesMichael Trauner, Peter Fickert, Emina Halilbasic, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 30, 2021
Diet and exercise in NAFLD/NASH: Beyond the obviousGeorg Semmler, Christian Datz, Thomas Reiberger, et al.
Journal of Hepatology|April 29, 2015
New paradigms in the treatment of hepatic cholestasis: from UDCA to FXR, PXR and beyondUlrich Beuers, Michael Trauner, Peter Jansen, et al.
Innere Medizin (Heidelberg, Germany)|March 18, 2024
[Primary sclerosing cholangitis-Diagnosis and treatment 2024]Michael Trauner, Emina Halilbasic, Elisabeth Tatscher, et al.
Best Practice & Research. Clinical Gastroenterology|April 19, 2011
Fibrosis in autoimmune and cholestatic liver diseaseMelitta Penz-Österreicher, Christoph H Österreicher, Michael Trauner
Liver International : Official Journal of the International Association for the Study of the Liver|November 22, 2011
Evolving concepts in primary sclerosing cholangitisElisabeth Krones, Ivo Graziadei, Michael Trauner, et al.
World Journal of Gastroenterology|October 30, 2019
Gut-liver axis signaling in portal hypertensionBenedikt Simbrunner, Mattias Mandorfer, Michael Trauner, et al.
Hepatology (Baltimore, Md.)|July 2, 2025
Benefits and challenges to therapeutic targeting of bile acid circulation in cholestatic liver diseaseMichael Trauner, Saul J Karpen, Paul A Dawson
Hepatology (Baltimore, Md.)|September 19, 2025
Bile acid signaling in MASLD: From pathogenesis to therapeutic applicationsBenedikt Simbrunner, Rafael Paternostro, Thomas Reiberger, et al.
Digestive Diseases (Basel, Switzerland)|June 23, 2016
Farnesoid X Receptor Agonists and Other Bile Acid Signaling Strategies for Treatment of Liver DiseaseEmina Halilbasic, Claudia Fuchs, Stefan Traussnigg, et al.
Pageof 121